BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hill A, Gupta R, Zhao D, Vankina R, Amanam I, Salgia R. Targeted Therapies in Non-small-Cell Lung Cancer. Cancer Treat Res 2019;178:3-43. [PMID: 31209840 DOI: 10.1007/978-3-030-16391-4_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang W, Sun H, Ma X, Zhu T, Zhang H. Circ_0002476 regulates cell growth, invasion, and mtDNA damage in non-small cell lung cancer by targeting miR-1182/TFAM axis. Thorac Cancer 2022. [PMID: 36056804 DOI: 10.1111/1759-7714.14631] [Reference Citation Analysis]
2 Hedayat M, Jafari R, Majidi Zolbanin N. Selumetinib: a selective MEK1 inhibitor for solid tumor treatment. Clin Exp Med 2022. [PMID: 35171389 DOI: 10.1007/s10238-021-00783-z] [Reference Citation Analysis]
3 Sun S, Du W, Sun Q, Zhao X, Qin B, Shi D, Wan C, Wu Z. Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy. Cancer Med 2021;10:7360-72. [PMID: 34599863 DOI: 10.1002/cam4.4178] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ren K, Sun J, Liu L, Yang Y, Li H, Wang Z, Deng J, Hou M, Qiu J, Zhao W. TP53-Activated lncRNA GHRLOS Regulates Cell Proliferation, Invasion, and Apoptosis of Non-Small Cell Lung Cancer by Modulating the miR-346/APC Axis. Front Oncol 2021;11:676202. [PMID: 33968785 DOI: 10.3389/fonc.2021.676202] [Reference Citation Analysis]
5 Hu DD, Chen HL, Lou LM, Zhang H, Yang GL. SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis. Biosci Rep 2020;40:BSR20194335. [PMID: 32068236 DOI: 10.1042/BSR20194335] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
6 Wang K, Chen Q, Shao Y, Yin S, Liu C, Liu Y, Wang R, Wang T, Qiu Y, Yu H. Anticancer activities of TCM and their active components against tumor metastasis. Biomed Pharmacother 2021;133:111044. [PMID: 33378952 DOI: 10.1016/j.biopha.2020.111044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li B, Zhang F, Li H. miR-1225-5p inhibits non-small cell lung cancer cell proliferation, migration and invasion, and may be a prognostic biomarker. Exp Ther Med 2020;20:172. [PMID: 33101465 DOI: 10.3892/etm.2020.9302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lin JH, Chen FN, Wu CX, Hu SQ, Ma J. Long non-coding RNA B4GALT1-Antisense RNA 1/microRNA-30e/SRY-box transcription factor 9 signaling axis contributes to non-small cell lung cancer cell growth. Oncol Lett 2020;20:284. [PMID: 33014162 DOI: 10.3892/ol.2020.12146] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Hu Y, Ren S, Liu Y, Han W, Liu W. Pulmonary Lymphoepithelioma-Like Carcinoma: A Mini-Review. Onco Targets Ther 2020;13:3921-9. [PMID: 32494151 DOI: 10.2147/OTT.S241337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]